Identification of a Novel Circadian Rhythm-Related Signature for Predicting Prognosis and Therapies in Hepatocellular Carcinoma Based on Bulk and Single-Cell RNA Sequencing

Figure 9

Prediction of the response to immunotherapy and chemotherapy in high-risk and low-risk groups. (a, b) Heatmap and histogram of the differentially expressed immune checkpoint-related genes between high-risk and low-risk groups. (c, d) Histogram of the differentially expressed TIDE value and IPS between high-risk and low-risk groups. (e, f) The differential IC₅₀ values of chemotherapeutic drugs between high-risk and low-risk groups.

(a)

(b)

(c)

(d)

(e)

(f)